Pfizer: One of the world's premier biopharmaceutical companies

Science Will Win

Our Products

Science Will Win

When science wins, we all win. Shop and share the collection, available in the U.S. only.
All profits from The Pfizer Store will be donated to charity.

SHOP THE PFIZER COLLECTION

Meet Ramcess Jean-Louis

Our People

Meet Ramcess Jean-Louis

Ready to build on Pfizer’s commitment to Diversity, Equity, and Inclusion

The Truth About COVID-19 and "Black Fungus"

Your Health

The Truth About COVID-19 and "Black Fungus"

Setting the record straight about a rare but fatal infection

LEARN MORE

Sickle Cell

Your Health

Sickle Cell

Is there a difference between having sickle cell trait and sickle cell disease? Find out what steps to take if you or someone in your family is diagnosed with these conditions.

Search products

Search products, A–Z

Need help paying for Pfizer medicines?

Your search for a clinical trial starts here.

Learn more about the process of joining a clinical trial and find a trial near you.

Start now

LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19

Our Science

LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19

Do you have COVID-19? We are currently enrolling participants in a clinical trial for a potential oral treatment option.

See If You Qualify

Visit Our COVID-19 Hub

Your Health

Visit Our COVID-19 Hub

What you need to know about the virus and updates on how Pfizer is responding to the crisis.

Visit our resources

Latest News

Valneva and Pfizer Report Further Positive Phase…

Saint-Herblain (France) and New York (United States), September 28, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE), today announced further positive Phase 2 results, including booster response, for Lyme disease vaccine candidate VLA15.